Claritev Free Cash Flow 2019-2026 | CTEV

Claritev free cash flow from 2019 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Claritev Annual Free Cash Flow
2025
2024 -10.51
2023 62.87
2022 282.63
2021 320.10
2020 306.56
2019 217.90
2018 228.75
Claritev Quarterly Free Cash Flow
2026-03-31
2025-12-31
2025-09-30 -48.65
2025-06-30 -32.31
2025-03-31 -68.92
2024-12-31 -10.51
2024-09-30 53.34
2024-06-30 12.20
2024-03-31 19.17
2023-12-31 62.87
2023-09-30 66.51
2023-06-30 16.81
2023-03-31 41.11
2022-12-31 282.63
2022-09-30 280.47
2022-06-30 192.24
2022-03-31 170.39
2021-12-31 320.10
2021-09-30 314.23
2021-06-30 167.60
2021-03-31 152.79
2020-12-31 306.56
2020-09-30 282.98
2020-06-30 157.00
2020-03-31 130.06
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.269B $0.965B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $24.733B 27.19
Tempus AI (TEM) United States $7.677B 0.00
Hims & Hers Health (HIMS) United States $4.429B 38.86
Doximity (DOCS) United States $3.888B 16.84
IRhythm Holdings (IRTC) United States $3.724B 0.00
10x Genomics (TXG) United States $2.973B 0.00
Privia Health (PRVA) United States $2.810B 131.59
Hinge Health (HNGE) United States $2.789B 0.00
Heartflow (HTFL) United States $2.311B 0.00
Omnicell (OMCL) United States $1.564B 43.00
Inspire Medical Systems (INSP) United States $1.555B 20.94
Enovis (ENOV) United States $1.405B 7.40
Butterfly Network (BFLY) United States $1.047B 0.00
Azenta (AZTA) United States $1.023B 41.13
Clover Health Investments (CLOV) United States $1.013B 0.00
Talkspace (TALK) United States $0.864B 103.40
Schrodinger (SDGR) United States $0.839B 0.00
Phreesia (PHR) United States $0.490B 50.38
Fulgent Genetics (FLGT) United States $0.429B 0.00
Standard BioTools (LAB) United States $0.345B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.322B 0.00
CapsoVision (CV) United States $0.311B 0.00
Senseonics Holdings (SENS) United States $0.279B 0.00
TruBridge (TBRG) United States $0.268B 8.60
Evolent Health (EVH) United States $0.260B 0.00
Carlsmed (CARL) United States $0.239B 0.00
KORU Medical Systems (KRMD) United States $0.196B 0.00
Zepp Health (ZEPP) Netherlands $0.189B 0.00
CareCloud (CCLD) United States $0.115B 8.18
Nyxoah SA (NYXH) Belgium $0.111B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
American Well (AMWL) United States $0.086B 0.00
Outset Medical (OM) United States $0.077B 0.00
Health Catalyst (HCAT) United States $0.073B 0.00
Pulmonx (LUNG) United States $0.058B 0.00
111 (YI) China $0.057B 0.00
NetraMark Holdings (AINMF) Canada $0.052B 0.00
Precipio (PRPO) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.047B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
P3 Health Partners (PIII) United States $0.018B 0.00
EUDA Health Holdings (EUDA) Singapore $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.009B 0.00
Zhongchao (ZCMD) China $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00